Finally, the HDCA5 gene is also involved in the ketamine-induced transcriptional regulation of the brain derived neurotrophic factor (BDNF), and its phosphorylation regulates the therapeutic actions of ketamine—a therapeutic agent for the treatment of depression and anxiety [38]. The gene discussed is BDNF; the disease is depressive symptom measurement.